Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 5,000 shares at $220.35 ($1.1M) on 2024-09-27, disclosed to the SEC on 2024-10-01.
Scheduled sale ($1.1M) by Global Head of R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |